Akari Therapeutics Plc Quarterly Common Stock, Value, Issued in USD from Q4 2011 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Summary
Akari Therapeutics Plc quarterly Common Stock, Value, Issued history and growth rate from Q4 2011 to Q3 2024.
  • Akari Therapeutics Plc Common Stock, Value, Issued for the quarter ending September 30, 2024 was $2.43M.
Common Stock, Value, Issued, Quarterly (USD)
Common Stock, Value, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $2.43M Sep 30, 2024 10-Q 2024-11-19
Q2 2024 $2.31K* -$1.01M Jun 30, 2024 8-K 2024-09-06
Q1 2024 $1.6M Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $1.32M +$1.32M Dec 31, 2023 10-Q 2024-11-19
Q2 2023 $1.01M +$419K +70.6% Jun 30, 2023 6-K 2023-09-29
Q4 2022 $1.98K* -$474K Dec 31, 2022 8-K 2024-09-06
Q2 2022 $593K +$197K +49.7% Jun 30, 2022 6-K 2022-09-27
Q4 2021 $476K +$91.2K +23.7% Dec 31, 2021 20-F 2023-05-01
Q2 2021 $396K -$46.2M -99.1% Jun 30, 2021 6-K 2021-09-22
Q4 2020 $385K -$31.6M -98.8% Dec 31, 2020 20-F 2022-05-16
Q3 2020 $46.6M +$16.5M +54.6% Sep 30, 2020 20-F 2021-04-21
Q2 2020 $46.6M +$22M +89.8% Jun 30, 2020 20-F 2021-04-21
Q1 2020 $40.1M +$16.4M +69% Mar 31, 2020 20-F 2021-04-21
Q4 2019 $32M +$8.34M +35.2% Dec 31, 2019 20-F 2021-04-21
Q3 2019 $30.1M Sep 30, 2019 20-F 2021-04-21
Q2 2019 $24.5M +$1.61M +7.03% Jun 30, 2019 20-F 2021-04-21
Q1 2019 $23.7M Mar 31, 2019 20-F 2021-04-21
Q4 2018 $23.7M +$724K +3.16% Dec 31, 2018 20-F 2020-03-31
Q2 2018 $22.9M +$4.59M +25% Jun 30, 2018 6-K 2018-09-27
Q4 2017 $22.9M +$4.59M +25% Dec 31, 2017 20-F 2019-04-23
Q2 2017 $18.3M $0 0% Jun 30, 2017 6-K 2017-08-10
Q4 2016 $18.3M $0 0% Dec 31, 2016 20-F 2018-07-18
Q2 2016 $18.3M +$17.4M +1879% Jun 30, 2016 6-K/A 2017-04-14
Q1 2016 $18.3M +$17.4M +1879% Mar 31, 2016 10-Q 2016-05-12
Q4 2015 $18.3M +$7.13M +63.6% Dec 31, 2015 6-K/A 2017-04-14
Q3 2015 $18.3M Sep 30, 2015 10-Q 2015-11-23
Q2 2015 $927K Jun 30, 2015 10-Q 2015-08-12
Q1 2015 $927K Mar 31, 2015 10-Q 2015-05-12
Q4 2014 $11.2M +$10.5M +1561% Dec 31, 2014 10-K 2016-03-23
Q4 2013 $675K +$430K +176% Dec 31, 2013 10-K 2015-02-11
Q4 2012 $245K +$20K +8.89% Dec 31, 2012 20-F 2014-03-24
Q4 2011 $225K Dec 31, 2011 20-F/A 2013-04-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.